Highlights for the
- Shipments of
$1,288 million and revenue of$1,426 million . - GAAP gross margin of 43.9%, GAAP operating margin of 16.8%, and GAAP diluted EPS of
$1.28 . - Non-GAAP gross margin of 45.5%, non-GAAP operating margin of 20.8%, and non-GAAP diluted EPS of
$1.57 .
Key Financial Data for the Quarters Ended |
||||||||||
(in thousands, except per-share data, percentages, and basis points) | ||||||||||
December 2015 | September 2015 | Change Q/Q | ||||||||
Shipments | $ | 1,287,893 | $ | 1,579,298 | -18 | % | ||||
Revenue | $ | 1,425,534 | $ | 1,600,043 | -11 | % | ||||
Gross margin as percentage of revenue | 43.9 | % | 45.1 | % | -120 bps | |||||
Operating margin as percentage of revenue | 16.8 | % | 21.0 | % | -420 bps | |||||
Diluted EPS | $ | 1.28 | $ | 1.66 | -23 | % | ||||
Non-GAAP | ||||||||||
December 2015 | September 2015 | Change Q/Q | ||||||||
Shipments | $ | 1,287,893 | $ | 1,579,298 | -18 | % | ||||
Revenue | $ | 1,425,534 | $ | 1,600,043 | -11 | % | ||||
Gross margin as percentage of revenue | 45.5 | % | 46.5 | % | -100 bps | |||||
Operating margin as percentage of revenue | 20.8 | % | 23.8 | % | -300 bps | |||||
Diluted EPS | $ | 1.57 | $ | 1.82 | -14 | % | ||||
For the
Non-GAAP Financial Results
For the
"Lam's strong December quarter concludes a historic year for Lam, headlined by the delivery of nearly
Balance Sheet and Cash Flow Results
Cash and cash equivalents, short-term investments, and restricted cash and investments balances increased to
Deferred revenue at the end of the
Geographic Distribution
The geographic distribution of shipments and revenue during the
Region | Shipments | Revenue | ||||
38 | % | 31 | % | |||
21 | % | 22 | % | |||
9 | % | 17 | % | |||
15 | % | 15 | % | |||
8 | % | 7 | % | |||
5 | % | 5 | % | |||
4 | % | 3 | % |
Outlook
For the
Reconciling Items | Non-GAAP | ||||||||
Shipments | +/- | - | +/- | ||||||
Revenue | +/- | - | +/- | ||||||
Gross margin | 42.4% | +/- | 1% | 44.0% | +/- | 1% | |||
Operating margin | 14.2% | +/- | 1% | 17.0% | +/- | 1% | |||
Net income per diluted share | +/- | +/- | |||||||
Diluted share count | 174.5 Million | 2 Million | 172.5 Million |
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release, and does not incorporate the potential impact of any KLA-Tencor related acquisition or integration expenses, business combinations, asset acquisitions, divestitures, financing arrangements, other investments, or other significant transactions that may be completed after the date of this release. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:
- Gross Margin -- amortization related to intangible assets acquired in the Novellus transaction,
$21 million . - Operating margin -- amortization related to intangible assets acquired in the Novellus transaction,
$37 million . - Earnings per share -- amortization related to intangible assets acquired in the Novellus transaction,
$37 million ; amortization of note discounts,$9 million ; amortization of bridge loan issuance costs associated with the KLA-Tencor acquisition,$18 million and associated tax benefit for non-GAAP items($14) million ; totaling$50 million . - Diluted share count -- impact of a note hedge issued contemporaneously with the convertible notes due 2016 and 2018, 2 million shares.
Use of Non-GAAP Financial Results
In addition to
Management uses non-GAAP gross margin, operating income, operating expenses, operating margin, net income, and net income per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors' ability to view the Company's results from management's perspective. Tables presenting reconciliations of non-GAAP results to
Cautionary Statement Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to; the estimated future revenue from shipments to Japanese customers, our expected revenue growth, our ability to continue to successfully execute our growth strategy and solve our customers' critical challenges through the delivery of differentiated products and services in market expanding technology inflections, our ability to achieve market growth gains at key inflections, our ability to continue to outperform, our commitment and ability to deliver growth and value for our customers and our stockholders; the nature of the capabilities we deliver for the benefit of the global semiconductor industry following our proposed acquisition of KLA-Tencor Corporation ("KLA-Tencor") (the "proposed transaction"); the extent of inflection driven expansion in our served available market, and our guidance for shipments, revenue, gross margin, operating margin, earnings per share, and diluted earnings per share and share count. Some factors that may affect these forward-looking statements include: the proposed transaction may not close and if it does close we may not receive the expected benefits of the proposed transaction, such as the scale and breadth of critical technologies and better financial performance for our stockholders; our stockholders and the KLA-Tencor stockholders may not support the proposed transaction; business conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate; and the strength of the financial position reflected in documents filed or furnished by us with the Securities and Exchange Commission, including specifically our annual report on Form 10-K for the fiscal year ended
Additional Information and Where to Find It
This document does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The proposed transaction will be submitted to the stockholders of each of Lam and KLA-Tencor for their consideration. On
Participants in the Solicitation
Lam, KLA-Tencor, their respective directors, and certain of their respective executive officers, other members of management and employees, may, under
About
Consolidated Financial Tables Follow.
LAM RESEARCH CORPORATION | |||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||||||||||||||
(in thousands, except per share data and percentages) | |||||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||||
2015 | 2015 | 2014 | 2015 | 2014 | |||||||||||||||||
(unaudited) | |||||||||||||||||||||
Revenue | $ | 1,425,534 | $ | 1,600,043 | $ | 1,232,241 | $ | 3,025,577 | $ | 2,384,609 | |||||||||||
Cost of goods sold | 799,024 | 877,680 | 695,584 | 1,676,704 | 1,342,413 | ||||||||||||||||
Gross margin | 626,510 | 722,363 | 536,657 | 1,348,873 | 1,042,196 | ||||||||||||||||
Gross margin as a percent of revenue | 43.9 | % | 45.1 | % | 43.6 | % | 44.6 | % | 43.7 | % | |||||||||||
Research and development | 220,754 | 234,209 | 196,768 | 454,963 | 385,702 | ||||||||||||||||
Selling, general and administrative | 166,922 | 152,726 | 151,148 | 319,648 | 299,455 | ||||||||||||||||
Total operating expenses | 387,676 | 386,935 | 347,916 | 774,611 | 685,157 | ||||||||||||||||
Operating income | 238,834 | 335,428 | 188,741 | 574,262 | 357,039 | ||||||||||||||||
Operating income as a percent of revenue | 16.8 | % | 21.0 | % | 15.3 | % | 19.0 | % | 15.0 | % | |||||||||||
Other expense, net | (29,935 | ) | (27,121 | ) | (9,799 | ) | (57,056 | ) | (15,447 | ) | |||||||||||
Income before income taxes | 208,899 | 308,307 | 178,942 | 517,206 | 341,592 | ||||||||||||||||
Income tax benefit (expense) | 14,081 | (19,628 | ) | (2,002 | ) | (5,547 | ) | (23,571 | ) | ||||||||||||
Net income | $ | 222,980 | $ | 288,679 | $ | 176,940 | $ | 511,659 | $ | 318,021 | |||||||||||
Net income per share: | |||||||||||||||||||||
Basic | $ | 1.41 | $ | 1.82 | $ | 1.11 | $ | 3.23 | $ | 1.98 | |||||||||||
Diluted | $ | 1.28 | $ | 1.66 | $ | 1.00 | $ | 2.94 | $ | 1.80 | |||||||||||
Number of shares used in per share calculations: | |||||||||||||||||||||
Basic | 158,424 | 158,352 | 159,248 | 158,388 | 160,467 | ||||||||||||||||
Diluted | 174,242 | 174,374 | 177,046 | 174,308 | 177,082 | ||||||||||||||||
Cash dividend declared per share | $ | 0.30 | $ | 0.30 | $ | 0.18 | $ | 0.60 | $ | 0.36 | |||||||||||
LAM RESEARCH CORPORATION | ||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||||
(in thousands) | ||||||||||
2015 | 2015 | 2015 | ||||||||
(unaudited) | (unaudited) | (1) | ||||||||
ASSETS | ||||||||||
Cash and cash equivalents | $ | 1,967,873 | $ | 1,744,325 | $ | 1,501,539 | ||||
Investments | 2,507,607 | 2,587,474 | 2,574,947 | |||||||
Accounts receivable, net | 1,089,850 | 1,088,942 | 1,093,582 | |||||||
Inventories | 879,821 | 916,683 | 943,346 | |||||||
Other current assets | 225,046 | 178,557 | 157,435 | |||||||
Total current assets | 6,670,197 | 6,515,981 | 6,270,849 | |||||||
Property and equipment, net | 643,746 | 636,769 | 621,418 | |||||||
Restricted cash and investments | 207,568 | 183,455 | 170,969 | |||||||
2,039,213 | 2,076,164 | 2,115,649 | ||||||||
Other assets | 189,697 | 182,062 | 185,763 | |||||||
Total assets | $ | 9,750,421 | $ | 9,594,431 | $ | 9,364,648 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||
Current portion of convertible notes and capital leases | $ | 973,697 | $ | 969,392 | $ | 1,359,650 | ||||
Other current liabilities | 1,249,283 | 1,312,549 | 1,271,711 | |||||||
Total current liabilities | 2,222,980 | 2,281,941 | 2,631,361 | |||||||
Long-term debt and capital leases | 1,404,683 | 1,400,615 | 1,001,382 | |||||||
Income taxes payable | 257,502 | 247,448 | 202,930 | |||||||
Other long-term liabilities | 135,303 | 127,607 | 184,023 | |||||||
Total liabilities | 4,020,468 | 4,057,611 | 4,019,696 | |||||||
Temporary equity, convertible notes | 177,662 | 178,665 | 241,808 | |||||||
Stockholders' equity (2) | 5,552,291 | 5,358,155 | 5,103,144 | |||||||
Total liabilities and stockholders' equity | $ | 9,750,421 | $ | 9,594,431 | $ | 9,364,648 | ||||
(1) Derived from audited financial statements | ||||||||||
(2) Common shares issued and outstanding were 158,568 as of |
||||||||||
LAM RESEARCH CORPORATION | |||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||||||||||
(in thousands) | |||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||
2015 | 2015 | 2014 | 2015 | 2014 | |||||||||||||||
(unaudited) | |||||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||
Net income | $ | 222,980 | $ | 288,679 | $ | 176,940 | $ | 511,659 | $ | 318,021 | |||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||||
Depreciation and amortization | 71,798 | 70,590 | 69,536 | 142,388 | 137,421 | ||||||||||||||
Deferred income taxes | 8,176 | (5,563 | ) | 3,320 | 2,613 | 6,506 | |||||||||||||
Equity-based compensation expense | 32,570 | 35,774 | 30,632 | 68,344 | 62,672 | ||||||||||||||
Income tax benefit on equity-based compensation plans | 2,168 | 3,545 | 1,141 | 5,713 | 11,002 | ||||||||||||||
Excess tax benefit on equity-based compensation plans | (2,181 | ) | (3,572 | ) | (599 | ) | (5,753 | ) | (11,003 | ) | |||||||||
Amortization of note discounts and issuance costs | 23,649 | 9,831 | 9,199 | 33,480 | 18,299 | ||||||||||||||
Gain on sale of business | - | - | - | - | (7,431 | ) | |||||||||||||
Other, net | 10,592 | 10,011 | 1,607 | 20,603 | 7,133 | ||||||||||||||
Changes in operating assets and liabilities | (75,207 | ) | 39,702 | (130,537 | ) | (35,505 | ) | (240,220 | ) | ||||||||||
Net cash provided by operating activities | 294,545 | 448,997 | 161,239 | 743,542 | 302,400 | ||||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||||||||||
Capital expenditures and intangible assets | (28,143 | ) | (49,454 | ) | (61,363 | ) | (77,597 | ) | (103,234 | ) | |||||||||
Business acquisitions, net of cash acquired | - | - | - | - | (1,137 | ) | |||||||||||||
Net sale (purchase) of available-for-sale securities | 39,202 | (28,203 | ) | (321,590 | ) | 10,999 | (311,945 | ) | |||||||||||
Repayment of notes receivable | 8,082 | - | 3,978 | 8,082 | 3,978 | ||||||||||||||
Proceeds from sale of business | - | - | - | - | 41,212 | ||||||||||||||
Other, net | (4,746 | ) | (1,500 | ) | 100 | (6,246 | ) | 122 | |||||||||||
Net cash provided by (used for) investing activities | 14,395 | (79,157 | ) | (378,875 | ) | (64,762 | ) | (371,004 | ) | ||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||||||||||
Principal payments on long-term debt and capital lease obligations and payments for debt issuance costs | (28,374 | ) | (96 | ) | (674 | ) | (28,470 | ) | (781 | ) | |||||||||
Excess tax benefit on equity-based compensation plans | 2,181 | 3,572 | 599 | 5,753 | 11,003 | ||||||||||||||
(12,798 | ) | (98,385 | ) | (65,536 | ) | (111,183 | ) | (373,958 | ) | ||||||||||
Dividends paid | (47,896 | ) | (47,659 | ) | (29,381 | ) | (95,555 | ) | (58,621 | ) | |||||||||
Re-issuance of treasury stock related to employee stock purchase plan | - | 19,245 | - | 19,245 | 16,919 | ||||||||||||||
Proceeds from issuance of common stock | 1,173 | 377 | 4,223 | 1,550 | 8,832 | ||||||||||||||
Other, net | (22 | ) | (300 | ) | - | (322 | ) | - | |||||||||||
Net cash used for financing activities | (85,736 | ) | (123,246 | ) | (90,769 | ) | (208,982 | ) | (396,606 | ) | |||||||||
Effect of exchange rate changes on cash and cash equivalents | 344 | (3,808 | ) | (3,998 | ) | (3,464 | ) | (6,192 | ) | ||||||||||
Net increase (decrease) in cash and cash equivalents | 223,548 | 242,786 | (312,403 | ) | 466,334 | (471,402 | ) | ||||||||||||
Cash and cash equivalents at beginning of period | 1,744,325 | 1,501,539 | 1,293,678 | 1,501,539 | 1,452,677 | ||||||||||||||
Cash and cash equivalents at end of period | $ | 1,967,873 | $ | 1,744,325 | $ | 981,275 | $ | 1,967,873 | $ | 981,275 | |||||||||
Non-GAAP Financial Summary | |||||||
(in thousands, except percentages and per share data) | |||||||
(unaudited) | |||||||
Three Months Ended | |||||||
2015 | 2015 | ||||||
Revenue | $ | 1,425,534 | $ | 1,600,043 | |||
Gross margin | $ | 648,409 | $ | 743,984 | |||
Gross margin as percentage of revenue | 45.5 | % | 46.5 | % | |||
Operating expenses | $ | 352,135 | $ | 363,596 | |||
Operating income | $ | 296,274 | $ | 380,388 | |||
Operating margin as a percentage of revenue | 20.8 | % | 23.8 | % | |||
Net income | $ | 270,313 | $ | 313,045 | |||
Net income per diluted share | $ | 1.57 | $ | 1.82 | |||
Shares used in per share calculation - diluted | 171,796 | 172,046 | |||||
Reconciliation of |
|||||||||||||||
(in thousands, except per share data) | |||||||||||||||
(unaudited) | |||||||||||||||
Three Months Ended | |||||||||||||||
2015 | 2015 | 2015 | 2015 | ||||||||||||
$ | 222,980 | $ | 288,679 | 131,271 | 206,285 | ||||||||||
Pre-tax non-GAAP items: | |||||||||||||||
Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold | 21,250 | 21,250 | 21,286 | 21,286 | |||||||||||
Acquisition-related inventory fair value impact - cost of goods sold | 649 | - | 1,192 | 308 | |||||||||||
Impairment of long lived asset - cost of goods sold | - | - | 9,821 | - | |||||||||||
Restructuring charges - cost of goods sold | - | 371 | - | - | |||||||||||
Restructuring charges - research and development | 34 | 4,206 | - | - | |||||||||||
Acquisition costs - selling, general and administrative | 17,392 | - | - | - | |||||||||||
Amortization related to intangible assets acquired in Novellus transaction - selling, general and administrative | 16,083 | 16,083 | 16,083 | 16,083 | |||||||||||
Restructuring charges - selling, general and administrative | 2,032 | 3,050 | 434 | (495 | ) | ||||||||||
- | - | 79,444 | - | ||||||||||||
Amortization of note discounts - other expense, net | 9,258 | 9,122 | 9,019 | 8,749 | |||||||||||
Amortization of bridge loan issuance costs - other expense, net | 13,573 | - | - | - | |||||||||||
Net income tax benefit on non-GAAP items | (19,335 | ) | (7,791 | ) | (9,605 | ) | (7,181 | ) | |||||||
Cumulative income tax benefit due to a court ruling | - | (21,925 | ) | - | - | ||||||||||
Income tax expense (benefit) on resolution or additional accrual for certain tax matters | - | - | 1,078 | (124 | ) | ||||||||||
Income tax benefit from tax extenders, primarily the research and development credit | (13,603 | ) | - | - | - | ||||||||||
Non-GAAP net income | $ | 270,313 | $ | 313,045 | $ | 260,023 | $ | 244,911 | |||||||
Non-GAAP net income per diluted share | $ | 1.57 | $ | 1.82 | $ | 1.50 | $ | 1.40 | |||||||
174,242 | 174,374 | 176,575 | 177,531 | ||||||||||||
Effect of convertible note hedge | (2,446 | ) | (2,328 | ) | (2,934 | ) | (3,060 | ) | |||||||
Non-GAAP number of shares used for per diluted share calculation | 171,796 | 172,046 | 173,641 | 174,471 | |||||||||||
Reconciliation of |
|||||||
(unaudited) | |||||||
Three Months Ended | |||||||
2015 | 2015 | ||||||
$ | 626,510 | $ | 722,363 | ||||
Pre-tax non-GAAP items: | |||||||
Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold | 21,250 | 21,250 | |||||
Acquisition-related inventory fair value impact - cost of goods sold | 649 | - | |||||
Restructuring charges - cost of goods sold | - | 371 | |||||
Non-GAAP gross margin | $ | 648,409 | $ | 743,984 | |||
43.9 | % | 45.1 | % | ||||
Non-GAAP gross margin as a percentage of revenue | 45.5 | % | 46.5 | % | |||
$ | 387,676 | $ | 386,935 | ||||
Pre-tax non-GAAP items: | |||||||
Restructuring charges - research and development | (34 | ) | (4,206 | ) | |||
Acquisition costs - selling, general and administrative | (17,392 | ) | - | ||||
Amortization related to intangible assets acquired in Novellus transaction - selling, general and administrative | (16,083 | ) | (16,083 | ) | |||
Restructuring charges - selling, general and administrative | (2,032 | ) | (3,050 | ) | |||
Non-GAAP operating expenses | $ | 352,135 | $ | 363,596 | |||
Non-GAAP operating income | $ | 296,274 | $ | 380,388 | |||
GAAP operating margin as percent of revenue | 16.8 | % | 21.0 | % | |||
Non-GAAP operating margin as a percent of revenue | 20.8 | % | 23.8 | % |
Lam Research Corporation Contacts:
Investor Relations
phone: 510-572-3232
e-mail: satya.kumar@lamresearch.com
Source:
News Provided by Acquire Media
Highlights for the
- Shipments of
$1,288 million and revenue of$1,426 million . - GAAP gross margin of 43.9%, GAAP operating margin of 16.8%, and GAAP diluted EPS of
$1.28 . - Non-GAAP gross margin of 45.5%, non-GAAP operating margin of 20.8%, and non-GAAP diluted EPS of
$1.57 .
Key Financial Data for the Quarters Ended |
||||||||||
(in thousands, except per-share data, percentages, and basis points) | ||||||||||
December 2015 | September 2015 | Change Q/Q | ||||||||
Shipments | $ | 1,287,893 | $ | 1,579,298 | -18 | % | ||||
Revenue | $ | 1,425,534 | $ | 1,600,043 | -11 | % | ||||
Gross margin as percentage of revenue | 43.9 | % | 45.1 | % | -120 bps | |||||
Operating margin as percentage of revenue | 16.8 | % | 21.0 | % | -420 bps | |||||
Diluted EPS | $ | 1.28 | $ | 1.66 | -23 | % | ||||
Non-GAAP | ||||||||||
December 2015 | September 2015 | Change Q/Q | ||||||||
Shipments | $ | 1,287,893 | $ | 1,579,298 | -18 | % | ||||
Revenue | $ | 1,425,534 | $ | 1,600,043 | -11 | % | ||||
Gross margin as percentage of revenue | 45.5 | % | 46.5 | % | -100 bps | |||||
Operating margin as percentage of revenue | 20.8 | % | 23.8 | % | -300 bps | |||||
Diluted EPS | $ | 1.57 | $ | 1.82 | -14 | % | ||||
For the
Non-GAAP Financial Results
For the
"Lam's strong December quarter concludes a historic year for Lam, headlined by the delivery of nearly
Balance Sheet and Cash Flow Results
Cash and cash equivalents, short-term investments, and restricted cash and investments balances increased to
Deferred revenue at the end of the
Geographic Distribution
The geographic distribution of shipments and revenue during the
Region | Shipments | Revenue | ||||
38 | % | 31 | % | |||
21 | % | 22 | % | |||
9 | % | 17 | % | |||
15 | % | 15 | % | |||
8 | % | 7 | % | |||
5 | % | 5 | % | |||
4 | % | 3 | % |
Outlook
For the
Reconciling Items | Non-GAAP | ||||||||
Shipments | +/- | - | +/- | ||||||
Revenue | +/- | - | +/- | ||||||
Gross margin | 42.4% | +/- | 1% | 44.0% | +/- | 1% | |||
Operating margin | 14.2% | +/- | 1% | 17.0% | +/- | 1% | |||
Net income per diluted share | +/- | +/- | |||||||
Diluted share count | 174.5 Million | 2 Million | 172.5 Million |
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release, and does not incorporate the potential impact of any KLA-Tencor related acquisition or integration expenses, business combinations, asset acquisitions, divestitures, financing arrangements, other investments, or other significant transactions that may be completed after the date of this release. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:
- Gross Margin -- amortization related to intangible assets acquired in the Novellus transaction,
$21 million . - Operating margin -- amortization related to intangible assets acquired in the Novellus transaction,
$37 million . - Earnings per share -- amortization related to intangible assets acquired in the Novellus transaction,
$37 million ; amortization of note discounts,$9 million ; amortization of bridge loan issuance costs associated with the KLA-Tencor acquisition,$18 million and associated tax benefit for non-GAAP items($14) million ; totaling$50 million . - Diluted share count -- impact of a note hedge issued contemporaneously with the convertible notes due 2016 and 2018, 2 million shares.
Use of Non-GAAP Financial Results
In addition to
Management uses non-GAAP gross margin, operating income, operating expenses, operating margin, net income, and net income per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors' ability to view the Company's results from management's perspective. Tables presenting reconciliations of non-GAAP results to
Cautionary Statement Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to; the estimated future revenue from shipments to Japanese customers, our expected revenue growth, our ability to continue to successfully execute our growth strategy and solve our customers' critical challenges through the delivery of differentiated products and services in market expanding technology inflections, our ability to achieve market growth gains at key inflections, our ability to continue to outperform, our commitment and ability to deliver growth and value for our customers and our stockholders; the nature of the capabilities we deliver for the benefit of the global semiconductor industry following our proposed acquisition of KLA-Tencor Corporation ("KLA-Tencor") (the "proposed transaction"); the extent of inflection driven expansion in our served available market, and our guidance for shipments, revenue, gross margin, operating margin, earnings per share, and diluted earnings per share and share count. Some factors that may affect these forward-looking statements include: the proposed transaction may not close and if it does close we may not receive the expected benefits of the proposed transaction, such as the scale and breadth of critical technologies and better financial performance for our stockholders; our stockholders and the KLA-Tencor stockholders may not support the proposed transaction; business conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate; and the strength of the financial position reflected in documents filed or furnished by us with the Securities and Exchange Commission, including specifically our annual report on Form 10-K for the fiscal year ended
Additional Information and Where to Find It
This document does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The proposed transaction will be submitted to the stockholders of each of Lam and KLA-Tencor for their consideration. On
Participants in the Solicitation
Lam, KLA-Tencor, their respective directors, and certain of their respective executive officers, other members of management and employees, may, under
About
Consolidated Financial Tables Follow.
LAM RESEARCH CORPORATION | |||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||||||||||||||
(in thousands, except per share data and percentages) | |||||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||||
2015 | 2015 | 2014 | 2015 | 2014 | |||||||||||||||||
(unaudited) | |||||||||||||||||||||
Revenue | $ | 1,425,534 | $ | 1,600,043 | $ | 1,232,241 | $ | 3,025,577 | $ | 2,384,609 | |||||||||||
Cost of goods sold | 799,024 | 877,680 | 695,584 | 1,676,704 | 1,342,413 | ||||||||||||||||
Gross margin | 626,510 | 722,363 | 536,657 | 1,348,873 | 1,042,196 | ||||||||||||||||
Gross margin as a percent of revenue | 43.9 | % | 45.1 | % | 43.6 | % | 44.6 | % | 43.7 | % | |||||||||||
Research and development | 220,754 | 234,209 | 196,768 | 454,963 | 385,702 | ||||||||||||||||
Selling, general and administrative | 166,922 | 152,726 | 151,148 | 319,648 | 299,455 | ||||||||||||||||
Total operating expenses | 387,676 | 386,935 | 347,916 | 774,611 | 685,157 | ||||||||||||||||
Operating income | 238,834 | 335,428 | 188,741 | 574,262 | 357,039 | ||||||||||||||||
Operating income as a percent of revenue | 16.8 | % | 21.0 | % | 15.3 | % | 19.0 | % | 15.0 | % | |||||||||||
Other expense, net | (29,935 | ) | (27,121 | ) | (9,799 | ) | (57,056 | ) | (15,447 | ) | |||||||||||
Income before income taxes | 208,899 | 308,307 | 178,942 | 517,206 | 341,592 | ||||||||||||||||
Income tax benefit (expense) | 14,081 | (19,628 | ) | (2,002 | ) | (5,547 | ) | (23,571 | ) | ||||||||||||
Net income | $ | 222,980 | $ | 288,679 | $ | 176,940 | $ | 511,659 | $ | 318,021 | |||||||||||
Net income per share: | |||||||||||||||||||||
Basic | $ | 1.41 | $ | 1.82 | $ | 1.11 | $ | 3.23 | $ | 1.98 | |||||||||||
Diluted | $ | 1.28 | $ | 1.66 | $ | 1.00 | $ | 2.94 | $ | 1.80 | |||||||||||
Number of shares used in per share calculations: | |||||||||||||||||||||
Basic | 158,424 | 158,352 | 159,248 | 158,388 | 160,467 | ||||||||||||||||
Diluted | 174,242 | 174,374 | 177,046 | 174,308 | 177,082 | ||||||||||||||||
Cash dividend declared per share | $ | 0.30 | $ | 0.30 | $ | 0.18 | $ | 0.60 | $ | 0.36 | |||||||||||
LAM RESEARCH CORPORATION | ||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||||
(in thousands) | ||||||||||
2015 | 2015 | 2015 | ||||||||
(unaudited) | (unaudited) | (1) | ||||||||
ASSETS | ||||||||||
Cash and cash equivalents | $ | 1,967,873 | $ | 1,744,325 | $ | 1,501,539 | ||||
Investments | 2,507,607 | 2,587,474 | 2,574,947 | |||||||
Accounts receivable, net | 1,089,850 | 1,088,942 | 1,093,582 | |||||||
Inventories | 879,821 | 916,683 | 943,346 | |||||||
Other current assets | 225,046 | 178,557 | 157,435 | |||||||
Total current assets | 6,670,197 | 6,515,981 | 6,270,849 | |||||||
Property and equipment, net | 643,746 | 636,769 | 621,418 | |||||||
Restricted cash and investments | 207,568 | 183,455 | 170,969 | |||||||
2,039,213 | 2,076,164 | 2,115,649 | ||||||||
Other assets | 189,697 | 182,062 | 185,763 | |||||||
Total assets | $ | 9,750,421 | $ | 9,594,431 | $ | 9,364,648 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||
Current portion of convertible notes and capital leases | $ | 973,697 | $ | 969,392 | $ | 1,359,650 | ||||
Other current liabilities | 1,249,283 | 1,312,549 | 1,271,711 | |||||||
Total current liabilities | 2,222,980 | 2,281,941 | 2,631,361 | |||||||
Long-term debt and capital leases | 1,404,683 | 1,400,615 | 1,001,382 | |||||||
Income taxes payable | 257,502 | 247,448 | 202,930 | |||||||
Other long-term liabilities | 135,303 | 127,607 | 184,023 | |||||||
Total liabilities | 4,020,468 | 4,057,611 | 4,019,696 | |||||||
Temporary equity, convertible notes | 177,662 | 178,665 | 241,808 | |||||||
Stockholders' equity (2) | 5,552,291 | 5,358,155 | 5,103,144 | |||||||
Total liabilities and stockholders' equity | $ | 9,750,421 | $ | 9,594,431 | $ | 9,364,648 | ||||
(1) Derived from audited financial statements | ||||||||||
(2) Common shares issued and outstanding were 158,568 as of |
||||||||||
LAM RESEARCH CORPORATION | |||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||||||||||
(in thousands) | |||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||
2015 | 2015 | 2014 | 2015 | 2014 | |||||||||||||||
(unaudited) | |||||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||
Net income | $ | 222,980 | $ | 288,679 | $ | 176,940 | $ | 511,659 | $ | 318,021 | |||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||||
Depreciation and amortization | 71,798 | 70,590 | 69,536 | 142,388 | 137,421 | ||||||||||||||
Deferred income taxes | 8,176 | (5,563 | ) | 3,320 | 2,613 | 6,506 | |||||||||||||
Equity-based compensation expense | 32,570 | 35,774 | 30,632 | 68,344 | 62,672 | ||||||||||||||
Income tax benefit on equity-based compensation plans | 2,168 | 3,545 | 1,141 | 5,713 | 11,002 | ||||||||||||||
Excess tax benefit on equity-based compensation plans | (2,181 | ) | (3,572 | ) | (599 | ) | (5,753 | ) | (11,003 | ) | |||||||||
Amortization of note discounts and issuance costs | 23,649 | 9,831 | 9,199 | 33,480 | 18,299 | ||||||||||||||
Gain on sale of business | - | - | - | - | (7,431 | ) | |||||||||||||
Other, net | 10,592 | 10,011 | 1,607 | 20,603 | 7,133 | ||||||||||||||
Changes in operating assets and liabilities | (75,207 | ) | 39,702 | (130,537 | ) | (35,505 | ) | (240,220 | ) | ||||||||||
Net cash provided by operating activities | 294,545 | 448,997 | 161,239 | 743,542 | 302,400 | ||||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||||||||||
Capital expenditures and intangible assets | (28,143 | ) | (49,454 | ) | (61,363 | ) | (77,597 | ) | (103,234 | ) | |||||||||
Business acquisitions, net of cash acquired | - | - | - | - | (1,137 | ) | |||||||||||||
Net sale (purchase) of available-for-sale securities | 39,202 | (28,203 | ) | (321,590 | ) | 10,999 | (311,945 | ) | |||||||||||
Repayment of notes receivable | 8,082 | - | 3,978 | 8,082 | 3,978 | ||||||||||||||
Proceeds from sale of business | - | - | - | - | 41,212 | ||||||||||||||
Other, net | (4,746 | ) | (1,500 | ) | 100 | (6,246 | ) | 122 | |||||||||||
Net cash provided by (used for) investing activities | 14,395 | (79,157 | ) | (378,875 | ) | (64,762 | ) | (371,004 | ) | ||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||||||||||
Principal payments on long-term debt and capital lease obligations and payments for debt issuance costs | (28,374 | ) | (96 | ) | (674 | ) | (28,470 | ) | (781 | ) | |||||||||
Excess tax benefit on equity-based compensation plans | 2,181 | 3,572 | 599 | 5,753 | 11,003 | ||||||||||||||
(12,798 | ) | (98,385 | ) | (65,536 | ) | (111,183 | ) | (373,958 | ) | ||||||||||
Dividends paid | (47,896 | ) | (47,659 | ) | (29,381 | ) | (95,555 | ) | (58,621 | ) | |||||||||
Re-issuance of treasury stock related to employee stock purchase plan | - | 19,245 | - | 19,245 | 16,919 | ||||||||||||||
Proceeds from issuance of common stock | 1,173 | 377 | 4,223 | 1,550 | 8,832 | ||||||||||||||
Other, net | (22 | ) | (300 | ) | - | (322 | ) | - | |||||||||||
Net cash used for financing activities | (85,736 | ) | (123,246 | ) | (90,769 | ) | (208,982 | ) | (396,606 | ) | |||||||||
Effect of exchange rate changes on cash and cash equivalents | 344 | (3,808 | ) | (3,998 | ) | (3,464 | ) | (6,192 | ) | ||||||||||
Net increase (decrease) in cash and cash equivalents | 223,548 | 242,786 | (312,403 | ) | 466,334 | (471,402 | ) | ||||||||||||
Cash and cash equivalents at beginning of period | 1,744,325 | 1,501,539 | 1,293,678 | 1,501,539 | 1,452,677 | ||||||||||||||
Cash and cash equivalents at end of period | $ | 1,967,873 | $ | 1,744,325 | $ | 981,275 | $ | 1,967,873 | $ | 981,275 | |||||||||
Non-GAAP Financial Summary | |||||||
(in thousands, except percentages and per share data) | |||||||
(unaudited) | |||||||
Three Months Ended | |||||||
2015 | 2015 | ||||||
Revenue | $ | 1,425,534 | $ | 1,600,043 | |||
Gross margin | $ | 648,409 | $ | 743,984 | |||
Gross margin as percentage of revenue | 45.5 | % | 46.5 | % | |||
Operating expenses | $ | 352,135 | $ | 363,596 | |||
Operating income | $ | 296,274 | $ | 380,388 | |||
Operating margin as a percentage of revenue | 20.8 | % | 23.8 | % | |||
Net income | $ | 270,313 | $ | 313,045 | |||
Net income per diluted share | $ | 1.57 | $ | 1.82 | |||
Shares used in per share calculation - diluted | 171,796 | 172,046 | |||||
Reconciliation of |
|||||||||||||||
(in thousands, except per share data) | |||||||||||||||
(unaudited) | |||||||||||||||
Three Months Ended | |||||||||||||||
2015 | 2015 | 2015 | 2015 | ||||||||||||
$ | 222,980 | $ | 288,679 | 131,271 | 206,285 | ||||||||||
Pre-tax non-GAAP items: | |||||||||||||||
Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold | 21,250 | 21,250 | 21,286 | 21,286 | |||||||||||
Acquisition-related inventory fair value impact - cost of goods sold | 649 | - | 1,192 | 308 | |||||||||||
Impairment of long lived asset - cost of goods sold | - | - | 9,821 | - | |||||||||||
Restructuring charges - cost of goods sold | - | 371 | - | - | |||||||||||
Restructuring charges - research and development | 34 | 4,206 | - | - | |||||||||||
Acquisition costs - selling, general and administrative | 17,392 | - | - | - | |||||||||||
Amortization related to intangible assets acquired in Novellus transaction - selling, general and administrative | 16,083 | 16,083 | 16,083 | 16,083 | |||||||||||
Restructuring charges - selling, general and administrative | 2,032 | 3,050 | 434 | (495 | ) | ||||||||||
- | - | 79,444 | - | ||||||||||||
Amortization of note discounts - other expense, net | 9,258 | 9,122 | 9,019 | 8,749 | |||||||||||
Amortization of bridge loan issuance costs - other expense, net | 13,573 | - | - | - | |||||||||||
Net income tax benefit on non-GAAP items | (19,335 | ) | (7,791 | ) | (9,605 | ) | (7,181 | ) | |||||||
Cumulative income tax benefit due to a court ruling | - | (21,925 | ) | - | - | ||||||||||
Income tax expense (benefit) on resolution or additional accrual for certain tax matters | - | - | 1,078 | (124 | ) | ||||||||||
Income tax benefit from tax extenders, primarily the research and development credit | (13,603 | ) | - | - | - | ||||||||||
Non-GAAP net income | $ | 270,313 | $ | 313,045 | $ | 260,023 | $ | 244,911 | |||||||
Non-GAAP net income per diluted share | $ | 1.57 | $ | 1.82 | $ | 1.50 | $ | 1.40 | |||||||
174,242 | 174,374 | 176,575 | 177,531 | ||||||||||||
Effect of convertible note hedge | (2,446 | ) | (2,328 | ) | (2,934 | ) | (3,060 | ) | |||||||
Non-GAAP number of shares used for per diluted share calculation | 171,796 | 172,046 | 173,641 | 174,471 | |||||||||||
Reconciliation of |
|||||||
(unaudited) | |||||||
Three Months Ended | |||||||
2015 | 2015 | ||||||
$ | 626,510 | $ | 722,363 | ||||
Pre-tax non-GAAP items: | |||||||
Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold | 21,250 | 21,250 | |||||
Acquisition-related inventory fair value impact - cost of goods sold | 649 | - | |||||
Restructuring charges - cost of goods sold | - | 371 | |||||
Non-GAAP gross margin | $ | 648,409 | $ | 743,984 | |||
43.9 | % | 45.1 | % | ||||
Non-GAAP gross margin as a percentage of revenue | 45.5 | % | 46.5 | % | |||
$ | 387,676 | $ | 386,935 | ||||
Pre-tax non-GAAP items: | |||||||
Restructuring charges - research and development | (34 | ) | (4,206 | ) | |||
Acquisition costs - selling, general and administrative | (17,392 | ) | - | ||||
Amortization related to intangible assets acquired in Novellus transaction - selling, general and administrative | (16,083 | ) | (16,083 | ) | |||
Restructuring charges - selling, general and administrative | (2,032 | ) | (3,050 | ) | |||
Non-GAAP operating expenses | $ | 352,135 | $ | 363,596 | |||
Non-GAAP operating income | $ | 296,274 | $ | 380,388 | |||
GAAP operating margin as percent of revenue | 16.8 | % | 21.0 | % | |||
Non-GAAP operating margin as a percent of revenue | 20.8 | % | 23.8 | % |
Lam Research Corporation Contacts:
Investor Relations
phone: 510-572-3232
e-mail: satya.kumar@lamresearch.com
Source:
News Provided by Acquire Media